Collectively, these findings indicate that, in this genetic context, CAF-derived IL-6 operates as a key cytokine pathway driving epithelial plasticity and invasiveness, suggesting that targeting CAFs to block the IL-6/JAK/STAT3 axis could diminish soluble-factor support to tumor cells and impede progression [146]. The gene discussed is IL6; the disease is neoplasm.